Skip to content
Disclosery

Valence8 US LP

Follow

13F filer, CIK 1943819, Cambridge, MA

Valence8 US LP reported $208,229,466 across 10 holdings for the quarter ended 2024-12-31, in a 13F-HR filed 2025-02-12.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001172661-25-000713

Period
2024-12-31
Reported value
$208M
Holdings
10
Top 10 weight
100%
New
1
Sold out
53

Largest buys vs the previous quarter

SecurityShares changeApprox. value
IGVnew+77,909$7.8M
EFVadded+5,062$266K
VTVadded+768$130K
XLPadded+894$70.3K
XLUadded+307$23.2K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
EWJreduced-49,985-$3.35M
EWUreduced-92,656-$3.14M
QQQreduced-4,351-$2.22M
QUALreduced-10,562-$1.88M
IQLTreduced-35,851-$1.33M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2024

Share positions as resolved from 13F-HR 0001172661-25-000713, largest first. % of portfolio is the value over $208,229,466, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
QUALISHARES TRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 337,472 shares; 2024Q4: 326,910 shares 326,910$58.2M27.96%-10,562Timeline
QQQINVESCO QQQ TRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 88,149 shares; 2024Q4: 83,798 shares 83,798$42.8M20.57%-4,351Timeline
IQLTISHARES TRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,026,290 shares; 2024Q4: 990,439 shares 990,439$36.8M17.66%-35,851Timeline
EFVISHARES TRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 399,186 shares; 2024Q4: 404,248 shares 404,248$21.2M10.19%+5,062Timeline
VTVVANGUARD INDEX FDSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 96,630 shares; 2024Q4: 97,398 shares 97,398$16.5M7.92%+768Timeline
XLPSELECT SECTOR SPDR TRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 165,267 shares; 2024Q4: 166,161 shares 166,161$13.1M6.27%+894Timeline
IGVISHARES TRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 77,909 shares 77,909$7.8M3.75%newTimeline
EWUISHARES TRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 209,344 shares; 2024Q4: 116,688 shares 116,688$3.96M1.9%-92,656Timeline
XLUSELECT SECTOR SPDR TRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 51,940 shares; 2024Q4: 52,247 shares 52,247$3.95M1.9%+307Timeline
EWJISHARES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 108,634 shares; 2024Q4: 58,649 shares 58,649$3.94M1.89%-49,985Timeline

Sold out in Q4 2024

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
AZNASTRAZENECA PLC-SPONS ADR64,000$4.99Mcall
JAZZJAZZ PHARMACEUTICALS PLC8,969$999Kshares
BMYBRISTOL-MYERS SQUIBB CO17,785$920Kshares
ASNDASCENDIS PHARMA A/S4,585$685Kshares
AMGNAMGEN INC2,000$644Kput
AMGNAMGEN INC2,000$644Kcall
SLNOSOLENO THERAPEUTICS INC12,500$631Kcall
CRSPCRISPR THERAPEUTICS AG13,100$615Kcall
INSMINSMED INC7,865$574Kshares
INDIVIOR PLCINDIVIOR PLC57,293$564Kshares
LLYELI LILLY & CO633$561Kshares
ARGXARGENX SE953$517Kshares
SLNOSOLENO THERAPEUTICS INC9,706$490Kshares
INSMINSMED INC6,600$482Kcall
KROSKEROS THERAPEUTICS INC8,025$466Kshares
NVONOVO-NORDISK A S3,900$464Kcall
NUVLNUVALENT INC4,115$421Kshares
FLNAFILANA THERAPEUTICS INC14,100$415Kput
RAREULTRAGENYX PHARMACEUTICAL IN6,900$383Kcall
APLSAPELLIS PHARMACEUTICALS INC13,100$378Kcall
JANXJANUX THERAPEUTICS INC7,857$357Kshares
AVADEL PHARMACEUTICALSAVADEL PHARMACEUTICALS26,200$344Kcall
CRNXCRINETICS PHARMACEUTICALS IN6,684$342Kshares
TYRATYRA BIOSCIENCES INC13,188$310Kshares
APGEAPOGEE THERAPEUTICS INC5,240$308Kshares
VRDNVIRIDIAN THERAPEUTICS INC13,100$298Kcall
PCVXVAXCYTE INC2,468$282Kshares
MRNAMODERNA INC4,100$274Kcall
NTLAINTELLIA THERAPEUTICS INC13,020$268Kshares
VIRVIR BIOTECHNOLOGY INC33,650$252Kshares
BLUEPRINT MEDICINES CORPBLUEPRINT MEDICINES CORP2,618$242Kshares
RAREULTRAGENYX PHARMACEUTICAL IN4,241$236Kshares
CLDXCELLDEX THERAPEUTICS INC NEW6,500$221Kput
ENTAENANTA PHARMACEUTICALS INC19,939$207Kshares
RLAYRELAY THERAPEUTICS INC26,200$185Kshares
Applied Therapeutics IncApplied Therapeutics Inc20,300$173Kcall
ALTALTIMMUNE INC26,200$161Kcall
ZVRAZEVRA THERAPEUTICS INC21,596$150Kshares
ALTALTIMMUNE INC23,500$144Kput
ERASERASCA INC46,923$128Kshares
IOVAIOVANCE BIOTHERAPEUTICS INC13,100$123Kcall
SLDBSOLID BIOSCIENCES INC15,728$110Kshares
JANXJANUX THERAPEUTICS INC2,300$104Kput
VTGNVISTAGEN THERAPEUTICS INC34,376$103Kshares
BCRXBIOCRYST PHARMACEUTICALS INC13,100$99.6Kcall
ZURAZURA BIO LTD17,495$71Kshares
ALECALECTOR INC14,708$68.5Kshares
CLYMCLIMB BIO INC12,045$61.3Kshares
CCCCC4 THERAPEUTICS INC10,500$59.9Kcall
CYPHCYPHERPUNK TECHNOLOGIES INC18,511$47.6Kshares
NEKTAR THERAPEUTICSNEKTAR THERAPEUTICS26,107$33.9Kshares
GOSSGOSSAMER BIO INC20,700$20.4Kcall
KEZAR LIFE SCIENCES INCKEZAR LIFE SCIENCES INC21,136$16.3Kshares

How Q4 2024 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001172661-25-000713 base2025-02-12acceptance time not in the bulk data set